New Possibilities of Antibiotic Therapy in Pediatric and Adult Ophthalmology

The problems of resistance to modern antibiotics and fluoroquinolones naturally stimulate interest in the development of eye dosage forms based on antiseptics. Today, their list has successfully supplemented the domestic drug Okomistin eye, ear, nasal drops (0.01 % — benzyldimethyl-myristoylamino-propylammonium), the manufacturer of Infamed-K. Numerous clinical studies performed, however, on adult patients, indicate a high therapeutic efficacy of the drug Okomistin®. However, with respect to children, the efficacy of Okomistin® remains unclear, although the drug has been approved for use by children from birth today. Objective. To evaluate the effectiveness of the Okomistin® in the treatment of children with bilateral bacterial conjunctivitis. Patients and Methods. Material research consisted of 30 children aged 3–16 years with bilateral acute bacterial conjunctivitis. 15 of them (26 eyes) received six-time instillations of the Okomistin® and 15 (24) — 0.05 % — Рicloxidin. All were subjected to traditional clinical examination and examination of the microflora of the conjunctival cavity with the determination of its sensitivity to antibiotics using the disk method. Results. In the spectrum of microflora found in the examined children, Staphylococcus Аureus dominated (14 eyes (53.8 %) — in the group of patients receiving Okomistin® and 13 (54.2 %) — Picloxidin), and Еpidermal Staphylococcus — 12 (46, 2 %) and 12 (50.0 %), respectively. Against the background of six-fold instillations of the compared drugs, a pronounced positive dynamics was established in relation to the relief of objective and subjective clinical symptoms of bacterial conjunctivitis already in the first week of treatment. At the same time, on the 7th day of therapy, in both groups of children, a significant decrease in the frequency of detection of microflora in the conjunctival cavity was noted, and on the 10th day, all the examined people underwent the contents of the conjunctival cavity to be sterile. Conclusion. The clinical efficacy of the Okomistin®, in combination with the absence of side effects of the drug and the affordable cost, allows recommending it for widespread practical use in pediatric and adult ophthalmology in the treatment of eye diseases of a bacterial nature. It seems promising to study the effectiveness of the drug in order to reorganize the conjunctival cavity in infants with dacryocystitis.

1. Vorontsova T.N., Mikhaylova M.V., Brzhesky V.V. The sensitivity and resistance of microflora to antibacterial drugs of the conjunctival cavity in children. Оphthalmology in Russia = Oftal’mologiya. 2012;9(1):83–91 (In Russ.). DOI: 10.18008/1816-5095-2012-1-83-91

2. Ozkan J., Willcox M., Wemheuer B. Biogeography of the human ocular microbiota. Ocular Surface (25 July 2018). DOI: 10.1016/j.jtos.2018.11.005

3. Zaitseva M.V., Brzhesky V.V., Malysheva M.O. The possibility of instillation of a solution of moxifloxacin 0.5 % in the perioperative preparation in children. Russian Pediatric Ophthalmology = Rossiiskaya pediatricheskaya oftalmologiya. 2018;13(1):14–20 (In Russ.). DOI: 10.18821/1993-1859-2018-13-1-14-20

4. Andersson J., Hofsli M., Gade U.L. Use of topical ocular antibiotics in young children: a Scandinavian drug utilization study. Acta Ophthalmologica. 2018; 96(8):789–794. DOI: 10.1111/aos.13813

5. Hua N., Ma W.J., Wang J.T. Normal conjunctival flora in healthy infants aged from 1 to 4 months. Chin. J. Ophthalmol. 2010;46:537–541.

6. Sankaridurg P.R., Markaulli M., De la Jara P.L. Lid and conjunctival microbiota during contact lens wear in children. Optom. Vis. Sci. 2009;86(4):312–317.

7. Okolov I.N., Gurchenok P.A., Vokhmyakov A.V. Normal conjunctival microflora in ophthalmic surgical patients. Ophthalmology journal = Oftal’mologicheskie vedomosti 2008;1(3):18–21 (In Russ.).

8. Suto C., Marinaga M., Yagi T., et al. Conjunctival sac bacterial flora isolated prior cataract surgery. Infect. Drug. Resist. 2012;5:37–41. DOI: 10.2147 / IDR.S27937

9. Vorontsova T.N., Brzhesky V.V., Efimova E.L., et al. The microflora of the conjunctival cavity and its sensitivity to antibacterial drugs in children are normal and in some inflammatory diseases of the eye. Ophthalmology journal = Oftal’mologicheskie vedomosti. 2010;2:61–65 (In Russ.).

10. Pozdnyakova V.V., Maychuk Yu.F. Okomistin eye drops in the treatment of infectious conjunctivitis of various etiologies. Ophthalmology journal = Oftal’mologicheskie vedomosti. 2012;5(2):67–71 (In Russ.).

11. Maychuk Yu.F., Seliverstova K.E., Yakushina L.N. Antiseptic Okomistin® in the treatment of bacterial eye diseases. Cataractal and refractive surgery = Cataraktal’naya i refrakcionnaya hirurgiJa. 2011;11(2)59–64 (In Russ.).

12. Maychuk Yu.F., Pozdnyakova V.V., Yakushina L.N., Kuznetsova I.V. The use of Okomistin® eye drops for conjunctivitis and blepharoconjunctivitis, accompanied by an allergic reaction. Cataractal and refractive surgery = Cataraktal’naya i refrakcionnaya hirurgiJa. 2011;11(4):65–68 (In Russ.).

13. Kirichenko I.M. Pharmacotherapy of infectious and inflammatory diseases of the anterior segment of the eye. Medicine = Meditsina. 2014;21(3):44–45 (In Russ.).

14. Gundorova R.A., Egorov V.A., Krivoshein Yu.S. The use of Miramistin in ophthalmology: The book for doctors. M., 2004. P. 8 (In Russ.).

15. Makarov I.A. The role of the antimicrobial drug Okomistin® in the complex treatment of chronic blepharoconjunctivitis. Ophthalmology journal = Oftal’mologicheskie vedomosti. 2015;8(4):53–58. (In Russ.). DOI: 10.17816/OV2015455-60

16. Velikokhatskaya T.A., Ustimenko S.B. Experience of using eye drops Okomistin® in the treatment of corneal epithelial injuries when wearing contact lenses. Cataractal and refractive surgery = Cataraktal’naya i refrakcionnaya hirurgiJa. 2011; 11(1):71–72 (In Russ.).

17. Rejtuzov V.A. The use of Okomistin® for the treatment and prevention of infectious and inflammatory diseases of the eye. Terra Medica. 2010; 4:20–23 (In Russ.).

18. Prozornaya L.P., Brzhesky V.V. The effective of the drug “Oftalmoferon” in the treatment of chronic blepharoconjunctivitis in children. Annals of Ophthalmology = Vestnik oftal’mologii. 2017;133(5):49–55 (In Russ.). DOI: 10.17116/oftalma2017133549-55

19. Pozdnyakova V.V., Yani E.V., Tokarev D.E. The combined use of eye drops Okomistin® and Ophthalmoferon® in the treatment of adenoviral conjunctivitis. Ophthalmic surgery = OftalmohirurgiJa. 2013;1:43–47 (In Russ.).

20. Astakhov Yu.S., Sokolov V.O., Morozova N.V. The tolerability and clinical efficacy of “OKOMISTIN” in combination with “Oftalmoferon” in comparison to “Oftalmoferon” as monotherapy in the treatment of adenoviral eye diseases Ophthalmology journal = Oftal’mologicheskie vedomosti. 2013;6(4):51–54 (In Russ.). DOI: 10.17816/OV2013451-54

21. Stebnev S.D. Experience in the use of the drug Okomistin in pre- and postoperative in patients with cataract. Ophthalmology in Russia = Oftalmologija. 2012;9(4):1–4 (In Russ.). DOI: 10.18008/1816-5095-2013-1-67-70

22. Gosteva N.N., Gosteva K.E. Experience with the use of the domestic drug Okomistin® eye drops after contact biomicroscopy of eyeball tissues. New in ophthalmology = Novoe v oftal’mologii. 2015;4:61–62 (In Russ.).

23. Brzhesky V.V., Chistyakova M.N., Raikova A.S., Brzheskaya I.V. Tactics of surgical treatment of impaired passage of the nasolacrimal duct in people of different ages. News of the Russian Military Medical Academy = Izvestia of the russian military medical academy. 2018;37(2):53–56 (In Russ.).